ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical toxicology 2020-07, Vol.16 (3), p.342-345
Hauptverfasser:	Stolbach, Andrew I., Mazer-Amirshahi, Maryann, Marino, Ryan, Nelson, Lewis S., Sugarman, Jeremy
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - drug effects Biomedical and Life Sciences Biomedicine Coronavirus Infections - drug therapy COVID-19 Emergency Medical Services - standards Humans Life Sciences & Biomedicine Off-Label Use - standards Off-Label Use - statistics & numerical data Pandemics Pharmacology/Toxicology Pneumonia, Viral - drug therapy Position Statement Practice Guidelines as Topic SARS-CoV-2 Science & Technology Toxicology United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!